Genelux Corporation Common Stock
$2.53
$0.00 (+0.00%)
$2.50Day Range$2.56
Key Statistics
Market Cap
$114.47M
Shares Outstanding
45.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 26, 2023
Round Lot
100
Locale
US
Trading Data
Day Open
$2.54
Day High
$2.56
Day Low
$2.50
Volume
143.1K
VWAP
$2.53
Prev Close
$2.53
Transactions
--
Acc. Volume
--
About Genelux Corporation Common Stock
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
PHARMACEUTICAL PREPARATIONSSIC 283426 employees2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361805-267-9889IPO Jan 26, 2023US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001231457
- Composite FIGI
- BBG0044BNBX6
- Share Class FIGI
- BBG0044BNBY5
- Ticker Root
- GNLX
- SIC Code
- 2834
About Genelux Corporation Common Stock (GNLX) Stock
Genelux Corporation Common Stock (GNLX) closed the 2026-09-18 session at $2.53, up 0.00% versus the previous close (+0.00). The stock opened at $2.54 and traded between $2.50 and $2.56 during that session. Session trading volume was 143K shares. The volume-weighted average price (VWAP) is $2.53.
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Genelux Corporation Common Stock has a market capitalization of $114.5 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. GNLX is listed on the XNAS exchange. The company employs approximately 26 people. Genelux Corporation Common Stock is headquartered in WESTLAKE VILLAGE, CA. The recorded listing date is 2023-01-26.
On this page you can find market GNLX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.